Modifiable Risk Factors for the Emergence of Ceftolozane-tazobactam Resistance

Abstract

Due to our small sample size, our results remain exploratory but forewarn of the potential emergence of TOL-TAZ resistance during therapy and suggest extending TOL-TAZ infusions may be protective. Larger studies are needed to investigate this association.